SHOO vs. CORT

Last updated Jun 9, 2026

SHOO (Steven Madden, Ltd.) and CORT (Corcept Therapeutics Incorporated) are both stocks. SHOO operates in Footwear & Accessories (Consumer Cyclical), while CORT operates in Biotechnology (Healthcare). Over the past 10 years, SHOO returned 8.85%/yr vs 29.33%/yr for CORT. At a 0.18 correlation, their price movements are largely independent.

Performance

SHOO vs. CORT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Steven Madden, Ltd. (SHOO) and Corcept Therapeutics Incorporated (CORT). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, SHOO achieves a 10.00% return, which is significantly lower than CORT's 110.72% return. Over the past 10 years, SHOO has underperformed CORT with an annualized return of 8.85%, while CORT has yielded a comparatively higher 29.33% annualized return.

SHOO

• 1D: 3.40%
• 1M: 12.11%
• YTD: 10.00%
• 6M: 6.84%
• 1Y: 87.20%
• 3Y*: 13.37%
• 5Y*: 2.86%
• 10Y*: 8.85%

CORT

• 1D: 0.98%
• 1M: 40.26%
• YTD: 110.72%
• 6M: -11.63%
• 1Y: 5.36%
• 3Y*: 46.50%
• 5Y*: 27.35%
• 10Y*: 29.33%

*Multi-year figures are annualized to reflect compound growth (CAGR)

SHOO vs. CORT - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
SHOO Steven Madden, Ltd.	10.00%	0.63%	3.21%	34.62%	-29.52%	33.46%	-17.43%	44.42%	-1.19%	30.63%
CORT Corcept Therapeutics Incorporated	110.72%	-30.94%	55.14%	59.92%	2.58%	-24.31%	116.20%	-9.43%	-26.02%	148.76%

Correlation

The correlation between SHOO and CORT is 0.23, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.23
Correlation (3Y) Calculated over the trailing 3-year period	0.26
Correlation (5Y) Calculated over the trailing 5-year period	0.26
Correlation (10Y) Calculated over the trailing 10-year period	0.20
Correlation (All Time) Calculated using the full available price history since Apr 14, 2004	0.18

Fundamentals

Market Cap SHOO : $3.26B CORT : $7.66B
EPS SHOO : $1.07 CORT : $0.41
PE Ratio SHOO : 42.47 CORT : 178.81
PS Ratio SHOO : 1.23 CORT : 11.07
PB Ratio SHOO : 3.57 CORT : 12.00
Total Revenue (TTM) SHOO : $2.63B CORT : $769.10M
Gross Profit (TTM) SHOO : $1.18B CORT : $755.64M
EBITDA (TTM) SHOO : $148.60M CORT : $3.66M

Return for Risk

SHOO vs. CORT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SHOO

SHOO Risk / Return Rank: 84
SHOO Sharpe Ratio Rank: 89
SHOO Sortino Ratio Rank: 84
SHOO Omega Ratio Rank: 83
SHOO Calmar Ratio Rank: 82
SHOO Martin Ratio Rank: 83

CORT

CORT Risk / Return Rank: 47
CORT Sharpe Ratio Rank: 44
CORT Sortino Ratio Rank: 47
CORT Omega Ratio Rank: 56
CORT Calmar Ratio Rank: 44
CORT Martin Ratio Rank: 44

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SHOO vs. CORT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Steven Madden, Ltd. (SHOO) and Corcept Therapeutics Incorporated (CORT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	SHOO	CORT	Difference
Sharpe ratio: Return per unit of total volatility	1.96	0.07	+1.89
Sortino ratio: Return per unit of downside risk	2.54	0.66	+1.88
Omega ratio: Gain probability vs. loss probability	1.33	1.14	+0.19
Calmar ratio: Return relative to maximum drawdown	2.76	0.08	+2.68
Martin ratio: Return relative to average drawdown	7.31	0.15	+7.16
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

SHOO vs. CORT - Sharpe Ratio Comparison

The current SHOO Sharpe Ratio is 1.96, which is higher than the CORT Sharpe Ratio of 0.07. The chart below compares the historical Sharpe Ratios of SHOO and CORT, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	SHOO	CORT	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.96	0.07	+1.89
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.07	0.37	-0.30
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.22	0.44	-0.22
Sharpe Ratio (All Time) Calculated using the full available price history	0.20	0.11	+0.09

Drawdowns

SHOO vs. CORT - Drawdown Comparison

The maximum SHOO drawdown since its inception was -77.06%, smaller than the maximum CORT drawdown of -94.28%. Use the drawdown chart below to compare losses from any high point for SHOO and CORT.

Drawdown Indicators

	SHOO	CORT	Difference
Max Drawdown Largest peak-to-trough decline	-77.06%	-94.28%	+17.22%
Max Drawdown (1Y) Largest decline over 1 year	-31.73%	-64.40%	+32.67%
Max Drawdown (3Y) Largest decline over 3 years	-60.21%	-71.85%	+11.64%
Max Drawdown (5Y) Largest decline over 5 years	-60.21%	-71.85%	+11.64%
Max Drawdown (10Y) Largest decline over 10 years	-60.21%	-71.85%	+11.64%
Current Drawdown Current decline from peak	-4.84%	-35.80%	+30.96%
Average Drawdown Average peak-to-trough decline	-22.85%	-53.44%	+30.59%
Ulcer Index Depth and duration of drawdowns from previous peaks	11.97%	35.34%	-23.37%

Volatility

SHOO vs. CORT - Volatility Comparison

The current volatility for Steven Madden, Ltd. (SHOO) is 9.99%, while Corcept Therapeutics Incorporated (CORT) has a volatility of 16.41%. This indicates that SHOO experiences smaller price fluctuations and is considered to be less risky than CORT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	SHOO	CORT	Difference
Volatility (1M) Calculated over the trailing 1-month period	9.99%	16.41%	-6.42%
Volatility (6M) Calculated over the trailing 6-month period	30.33%	85.07%	-54.74%
Volatility (1Y) Calculated over the trailing 1-year period	44.82%	76.73%	-31.91%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	39.12%	74.52%	-35.40%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	40.39%	67.22%	-26.83%

Dividends

SHOO vs. CORT - Dividend Comparison

SHOO's dividend yield for the trailing twelve months is around 2.32%, while CORT has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018
CORT Corcept Therapeutics Incorporated	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
SHOO Steven Madden, Ltd.	2.32%	2.02%	1.98%	2.00%	2.63%	1.29%	0.42%	1.33%	1.78%

Financials

SHOO vs. CORT - Profitability Comparison

The chart below illustrates the profitability comparison between Steven Madden, Ltd. and Corcept Therapeutics Incorporated over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

SHOO - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Steven Madden, Ltd. reported a gross profit of 357.42M and revenue of 653.10M. Therefore, the gross margin over that period was 54.7%.

CORT - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Corcept Therapeutics Incorporated reported a gross profit of 162.02M and revenue of 164.90M. Therefore, the gross margin over that period was 98.3%.

SHOO - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Steven Madden, Ltd. reported an operating income of 98.74M and revenue of 653.10M, resulting in an operating margin of 15.1%.

CORT - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Corcept Therapeutics Incorporated reported an operating income of -49.60M and revenue of 164.90M, resulting in an operating margin of -30.1%.

SHOO - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Steven Madden, Ltd. reported a net income of 71.82M and revenue of 653.10M, resulting in a net margin of 11.0%.

CORT - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Corcept Therapeutics Incorporated reported a net income of -31.20M and revenue of 164.90M, resulting in a net margin of -18.9%.

Frequently Asked Questions

Can I hold both SHOO and CORT in my portfolio?

SHOO and CORT have a correlation of 0.23, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, SHOO or CORT?

CORT has higher volatility (16.41%) compared to SHOO (9.99%). In terms of maximum drawdown, SHOO dropped -77.06% vs CORT's -94.28%.

Which has better risk-adjusted returns?

SHOO currently has the higher Sharpe Ratio (1.96 vs 0.07), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.